Skip to main content

Advertisement

Log in

A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large cohort of PBMAH patients. A multicenter study was performed, collecting patients from different endocrinology units in Italy. Seventy-one PBMAH patients were screened for small mutations and large rearrangements in the ARMC5 gene: 53 were cortisol-secreting (two with a family history of adrenal hyperplasia) and 18 were non-secreting cases of PBMAH. Non-mutated and mutated patients’ clinical phenotypes were compared and related to the type of mutation. A likely causative germline ARMC5 mutation was only identified in cortisol-secreting PBMAH patients (one with a family history of adrenal hyperplasia and ten apparently sporadic cases). Screening in eight first-degree relatives of three index cases revealed four carriers of an ARMC5 mutation. Evidence of a second hit at somatic level was identified in five nodules. Mutated patients had higher cortisol levels (p = 0.062), and more severe hypertension and diabetes (p < 0.05). Adrenal glands were significantly larger, with a multinodular phenotype, in the mutant group (p < 0.01). No correlation emerged between type of mutation and clinical parameters. ARMC5 mutations are frequent in cortisol-secreting PBMAH and seem to be associated with a particular pattern of the adrenal masses. Their identification may have implications for the clinical care of PBMAH cases and their relatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. A. Lacroix, ACTH-independent macronodular adrenal hyperplasia. Best Pract. Res. Clin. Endocrinol. Metab. 23, 245–259 (2009)

    Article  CAS  PubMed  Google Scholar 

  2. E. Louiset, C. Duparc, J. Young, S. Renouf, M. Tetsi Nomigni, I. Boutelet, R. Libe, Z. Bram, L. Groussin, P. Caron, A. Tabarin, F. Grunenberger, S. Christin-Maitre, X. Bertagna, J.M. Kuhn, Y. Anouar, J. Bertherat, H. Lefebvre, Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N. Engl. J. Med. 369, 2115–2125 (2013)

    Article  CAS  PubMed  Google Scholar 

  3. N.M. Albiger, G. Occhi, B. Mariniello, M. Iacobone, G. Favia, A. Fassina, D. Faggian, F. Mantero, C. Scaroni, Food-dependent Cushing’s syndrome: from molecular characterization to therapeutical results. Eur. J. Endocrinol. 157, 771–778 (2007)

    Article  CAS  PubMed  Google Scholar 

  4. N. El Ghorayeb, I. Bourdeau, A. Lacroix, Multiple aberrant hormone receptors in Cushing’s syndrome. Eur. J. Endocrinol. 173, M45–M60 (2015)

    Article  PubMed  Google Scholar 

  5. A. Horvath, S. Boikos, C. Giatzakis, A. Robinson-White, L. Groussin, K.J. Griffin, E. Stein, E. Levine, G. Delimpasi, H.P. Hsiao, M. Keil, S. Heyerdahl, L. Matyakhina, R. Libe, A. Fratticci, L.S. Kirschner, K. Cramer, R.C. Gaillard, X. Bertagna, J.A. Carney, J. Bertherat, I. Bossis, C.A. Stratakis, A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet. 38, 794–800 (2006)

    Article  CAS  PubMed  Google Scholar 

  6. D. Vezzosi, R. Libe, C. Baudry, M. Rizk-Rabin, A. Horvath, I. Levy, F. Rene-Corail, B. Ragazzon, C.A. Stratakis, G. Vandecasteele, J. Bertherat, Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors. J. Clin. Endocrinol. Metab. 97, E2063–E2069 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. A. Rothenbuhler, A. Horvath, R. Libe, F.R. Faucz, A. Fratticci, M.L. Raffin Sanson, D. Vezzosi, M. Azevedo, I. Levy, M.Q. Almeida, M. Lodish, M. Nesterova, J. Bertherat, C.A. Stratakis, Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours. Clin. Endocrinol. (Oxf.) 77, 195–199 (2012)

    Article  CAS  Google Scholar 

  8. G. Di Dalmazi, C. Kisker, D. Calebiro, M. Mannelli, L. Canu, G. Arnaldi, M. Quinkler, N. Rayes, A. Tabarin, M. Laure Jullie, F. Mantero, B. Rubin, J. Waldmann, D.K. Bartsch, R. Pasquali, M. Lohse, B. Allolio, M. Fassnacht, F. Beuschlein, M. Reincke, Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing’s syndrome: a European multicentric study. J. Clin. Endocrinol. Metab. 99, E2093–E2100 (2014)

    Article  PubMed  Google Scholar 

  9. F. Beuschlein, M. Fassnacht, G. Assie, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. G. Assie, R. Libe, S. Espiard, M. Rizk-Rabin, A. Guimier, W. Luscap, O. Barreau, L. Lefevre, M. Sibony, L. Guignat, S. Rodriguez, K. Perlemoine, F. Rene-Corail, F. Letourneur, B. Trabulsi, A. Poussier, N. Chabbert-Buffet, F. Borson-Chazot, L. Groussin, X. Bertagna, C.A. Stratakis, B. Ragazzon, J. Bertherat, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome. N. Engl. J. Med. 369, 2105–2114 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. F.R. Faucz, M. Zilbermint, M.B. Lodish, E. Szarek, G. Trivellin, N. Sinaii, A. Berthon, R. Libe, G. Assie, S. Espiard, L. Drougat, B. Ragazzon, J. Bertherat, C.A. Stratakis, Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J. Clin. Endocrinol. Metab. 99, E1113–E1119 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. G.A. Alencar, A.M. Lerario, M.Y. Nishi, B.M. Mariani, M.Q. Almeida, J. Tremblay, P. Hamet, I. Bourdeau, M.C. Zerbini, M.A. Pereira, G.C. Gomes, S. Rocha Mde, J.L. Chambo, A. Lacroix, B.B. Mendonca, M.C. Fragoso, ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 99, E1501–E1509 (2014)

    Article  CAS  PubMed  Google Scholar 

  13. L. Gagliardi, A.W. Schreiber, C.N. Hahn, J. Feng, T. Cranston, H. Boon, C. Hotu, B.E. Oftedal, R. Cutfield, D.L. Adelson, W.J. Braund, R.D. Gordon, D.A. Rees, A.B. Grossman, D.J. Torpy, H.S. Scott, Armc5 mutations are common in familial bilateral macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. (2014). doi:10.1210/jc.20141265

    Google Scholar 

  14. S. Espiard, L. Drougat, R. Libe, G. Assie, K. Perlemoine, L. Guignat, G. Barrande, F. Brucker-Davis, F. Doullay, S. Lopez, E. Sonnet, F. Torremocha, D. Pinsard, N. Chabbert-Buffet, M.L. Raffin-Sanson, L. Groussin, F. Borson-Chazot, J. Coste, X. Bertagna, C.A. Stratakis, F. Beuschlein, B. Ragazzon, J. Bertherat, armc5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J. Clin. Endocrinol. Metab. 100, E926–E935 (2015)

    Article  CAS  PubMed  Google Scholar 

  15. G. Occhi, M. Losa, N. Albiger, G. Trivellin, D. Regazzo, M. Scanarini, J.L. Monteserin-Garcia, B. Frohlich, S. Ferasin, M.R. Terreni, A. Fassina, L. Vitiello, G. Stalla, F. Mantero, C. Scaroni, The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. J. Neuroendocrinol. 23, 641–649 (2011)

    Article  CAS  PubMed  Google Scholar 

  16. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, C.T. Wittwer, The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611–622 (2009)

    Article  CAS  PubMed  Google Scholar 

  17. U. Elbelt, A. Trovato, M. Kloth, E. Gentz, R. Finke, J. Spranger, D. Galas, S. Weber, C. Wolf, K. Konig, W. Arlt, R. Buttner, P. May, B. Allolio, J.G. Schneider, Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. J. Clin. Endocrinol. Metab. 100, E119–E128 (2015)

    Article  CAS  PubMed  Google Scholar 

  18. P. Mulatero, F. Schiavi, T.A. Williams, S. Monticone, G. Barbon, G. Opocher, F. Fallo: ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions. J. Hum. Hypertens. doi:10.1038/jhh.2015.98 (2015)

    PubMed  Google Scholar 

  19. M. Zilbermint, P. Xekouki, F.R. Faucz, A. Berthon, A. Gkourogianni, M.H. Schernthaner-Reiter, M. Batsis, N. Sinaii, M.M. Quezado, M. Merino, A. Hodes, S.B. Abraham, R. Libe, G. Assie, S. Espiard, L. Drougat, B. Ragazzon, A. Davis, S.Y. Gebreab, R. Neff, E. Kebebew, J. Bertherat, M.B. Lodish, C.A. Stratakis, Primary aldosteronism and ARMC5 variants. J. Clin. Endocrinol. Metab. 100, E900–E909 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. S. Suzuki, I. Tatsuno, E. Oohara, A. Nakayama, E. Komai, A. Shiga, T. Kono, T. Takiguchi, S. Higuchi, I. Sakuma, H. Nagano, N. Hashimoto, T. Mayama, H. Koide, H. Sasano, Y. Nakatani, T. Imamoto, T. Ichikawa, K. Yokote, T. Tanaka, Germline deletion of Armc5 in familial primary macronodular adrenal hyperplasia. Endocr. Pract. 21, 1152–1160 (2015)

    Article  PubMed  Google Scholar 

  21. M. Khajavi, K. Inoue, J.R. Lupski, Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur. J. Hum. Genet. 14, 1074–1081 (2006)

    Article  CAS  PubMed  Google Scholar 

  22. E.D. Austin, J.A. Phillips, J.D. Cogan, R. Hamid, C. Yu, K.C. Stanton, C.A. Phillips, L.A. Wheeler, I.M. Robbins, J.H. Newman, J.E. Loyd, Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respir. Res. 10, 87 (2009). doi:10.1186/1465-9921-10-87

    Article  PubMed  PubMed Central  Google Scholar 

  23. M. Morey, L. Castro-Feijoo, J. Barreiro, P. Cabanas, M. Pombo, M. Gil, I. Bernabeu, J.M. Diaz-Grande, L. Rey-Cordo, G. Ariceta, I. Rica, J. Nieto, R. Vilalta, L. Martorell, J. Vila-Cots, F. Aleixandre, A. Fontalba, L. Soriano-Guillen, J.M. Garcia-Sagredo, S. Garcia-Minaur, B. Rodriguez, S. Juaristi, C. Garcia-Pardos, A. Martinez-Peinado, J.M. Millan, A. Medeira, O. Moldovan, A. Fernandez, L. Loidi, Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate. BMC Med. Genet. (2011). doi:10.1186/1471-2350-12-116

    PubMed  PubMed Central  Google Scholar 

  24. R. Correa, M. Zilbermint, A. Berthon, S. Espiard, M. Batsis, G.Z. Papadakis, P. Xekouki, M.B. Lodish, J. Bertherat, F.R. Faucz, C.A. Stratakis, The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur. J. Endocrinol. 173, 435–440 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. C.A. Stratakis, S.A. Boikos, Genetics of adrenal tumors associated with Cushing’s syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat. Clin. Pract. Endocrinol. Metab. 3, 748–757 (2007)

    Article  CAS  PubMed  Google Scholar 

  26. N.M. Albiger, F. Ceccato, M. Zilio, M. Barbot, G. Occhi, S. Rizzati, A. Fassina, F. Mantero, M. Boscaro, M. Iacobone, C. Scaroni, An analysis of different therapeutic options in patients with Cushing’s syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. Clin. Endocrinol. (Oxf) 82, 808–815 (2015)

    Article  CAS  Google Scholar 

  27. M. Iacobone, N. Albiger, C. Scaroni, F. Mantero, A. Fassina, G. Viel, M. Frego, G. Favia, The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J. Surg. 32, 882–889 (2008)

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the following people for all their help in patients’ collection and characterization during this study: Dr Laura Trementino, Dr Paola Sartorato, Dr Mattia Barbot, Dr Marialuisa Zilio, Dr Margherita Rizzato, and Prof Franco Mantero.

Funding

This work was funded by the Italian Ministry of University and Research (MIUR) through the FIRB project no. RBAP1153LS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Occhi.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

N. M. Albiger, D. Regazzo, G. Occhi and C. Scaroni have equally contributed to this work.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albiger, N.M., Regazzo, D., Rubin, B. et al. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype. Endocrine 55, 959–968 (2017). https://doi.org/10.1007/s12020-016-0956-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-0956-z

Keywords

Navigation